The purpose of the present invention is to provide a prophylactic or therapeutic agent for fatty liver diseases which is effective against non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), in particular. The present invention relates to a prophylactic or therapeutic agent for fatty liver diseases and is characterized by containing ibudilast as an active ingredient.